Valuation: Samsung Biologics Co.,Ltd.

Capitalization 88,323B 59.88B 51.49B 47.96B 44.69B 83.2B 5,407B 89.65B 553B 217B 2,585B 225B 220B 9,559B P/E ratio 2025 *
57.5x
P/E ratio 2026 * 47.4x
Enterprise value 87B 58.98M 50.72M 47.24M 44.02M 81.95M 5.33B 88.3M 544M 213M 2.55B 221M 217M 9.42B EV / Sales 2025 *
15.2x
EV / Sales 2026 * 13.8x
Free-Float
25.44%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.64%
1 week+90.80%
Current month+90.80%
1 month+90.80%
3 months+90.80%
6 months+90.80%
Current year+90.80%
More quotes
1 week 1,000,000
Extreme 999999.9999
1,944,000
1 month 1,000,000
Extreme 999999.9999
1,944,000
Current year 1,000,000
Extreme 999999.9999
1,944,000
1 year 1,000,000
Extreme 999999.9999
1,944,000
3 years 1,000,000
Extreme 999999.9999
1,944,000
5 years 1,000,000
Extreme 999999.9999
1,944,000
10 years 192,960.76
Extreme 192960.7607
1,944,000
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 09/12/2020
Director of Finance/CFO 58 14/03/2025
Investor Relations Contact 59 01/01/2014
Director TitleAgeSince
Chairman 64 09/12/2020
Director/Board Member 72 29/03/2022
Director/Board Member 67 20/03/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.64%+90.80%+90.80%+90.80% 58.65B
-1.18%-0.57%+8.90%+6.21% 78.8B
+0.91%+8.22%+30.29%+225.98% 55.89B
-0.08%+2.86%-38.18%-38.83% 56.73B
-3.95%+2.10%+19.81%-38.11% 27.23B
-2.73%+1.61%+46.63%+28.56% 20.87B
-0.11%+6.88%+166.32%+125.06% 19.74B
+0.42%+1.92%+54.28%+1,235.66% 17.33B
+2.95%+7.75%+172.04%+807.22% 14.81B
-0.04%-.--%+39.00%+171.78% 14.02B
Average -0.12%+4.12%+58.99%+261.43% 36.41B
Weighted average by Cap. -0.03%+4.13%+39.51%+148.45%
See all sector performances

Financials

2025 *2026 *
Net sales 5,722B 3.88B 3.34B 3.11B 2.9B 5.39B 350B 5.81B 35.81B 14.04B 167B 14.56B 14.25B 619B 6,223B 4.22B 3.63B 3.38B 3.15B 5.86B 381B 6.32B 38.95B 15.27B 182B 15.83B 15.5B 674B
Net income 1,634B 1.11B 953M 887M 827M 1.54B 100B 1.66B 10.23B 4.01B 47.82B 4.16B 4.07B 177B 1,899B 1.29B 1.11B 1.03B 961M 1.79B 116B 1.93B 11.88B 4.66B 55.58B 4.83B 4.73B 206B
Net Debt -1,325B -898M -773M -720M -671M -1.25B -81.12B -1.35B -8.29B -3.25B -38.78B -3.37B -3.3B -143B -2,588B -1.75B -1.51B -1.41B -1.31B -2.44B -158B -2.63B -16.19B -6.35B -75.73B -6.58B -6.45B -280B
More financial data * Estimated data
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
4,770
More about the company
Date Price Change Volume
13/01/26 1,908,000.00 +2.64% 77,125
12/01/26 1,859,000.00 -1.01% 68,736
09/01/26 1,878,000.00 -0.37% 70,385
08/01/26 1,885,000.00 +6.68% 128,454
07/01/26 1,767,000.00 +2.67% 61,546

End-of-day quote Korea S.E., 13 January 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
1,908,000.00KRW
Average target price
2,249,248.65KRW
Spread / Average Target
+17.89%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A207940 Stock